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Mellein and its derivatives are the most common 3,4-dihydroisocoumarins and are known to 
exhibit an array of biological activities such as antibacterial, antifungal, antimalarial, 
antiallergic, antitumor, anti-inflammatory, antiulcer, pheromonal, plant growth-promoting and 
antileukemic activities. Other mellein derivatives are recognized phytotoxins, neurotoxins, 
hepatotoxins, nephrotoxins and teratogens. Consequently, considerable efforts have been directed 
at studying these natural products. While most of the reported studies have focused on the 
isolation, characterization and bioassay studies of melleins, a number of synthetic studies have 
also been reported. This paper focuses on synthetic approaches towards these biologically active 
and, thus, potentially useful natural products. The aim is to bring together some of the earliest 
(past) and the more recent (present) and, concurrently, propose prospective (projected) synthetic 
methodologies. Therefore, this paper provides an overview of the existing and some potential 
synthetic routes toward melleins and, thus, provides a researcher with ideas and opportunities to 
choose and apply one or a blend of these synthetic strategies depending on accessible research 
facilities.  Moreover, the projected synthetic strategies focus on the utilization of anacardic acid 
from Cashew Nut Shell Liquid (CNSL) - a readily available natural resource. Utilization of CNSL, 
which is considered a waste product, adds value to the cashew crop. 
 




(R)-(-)-Mellein (1) and (S)-(+)-mellein (1′) 
as well as their derivatives such as 2-14 [Fig. 
1 (a) -(d)] are the most commonly occurring 
3,4-dihydroisocoumarins (3,4-DHICs). The 
common name mellein is derived from 
Aspergillus melleus, the fungus from which 
compound 1 was first isolated in 1933 
(Chacón-Morales et al. 2013 and references 
cited therein). Compound 1 and related 
fungal metabolites were later isolated from 
many other different sources including 
Aspergillus ochraceus, a source that led to 
these compounds to be also commonly 















Figure 1: Structures of (R)-(-)-mellein, (S)-(+)-mellein, (3R,4R)-(-)-4-hydroxymellein, 
(3R,4S)-(-)-4-hydroxymellein (1, 1′, 2, and 3, respectively) and other mellein 
derivatives (4-14) 
 
Based on structural similarities, the 3,4-
dihydroisocoumarins can in general be 
divided into a number of classes; one such 
class is that of the abovementioned mellein 
(1) and its very close derivatives (the other 
3-methyl-3,4-dihydroisocoumarins) 
illustrated in Figure 1  (a) - (d). The other 
classes include the 3-alkyl derivatives (apart 
from the 3-methyl-3,4-
dihydroisocoumarins), 3-aryl derivatives (3-
phenyl derivatives), aminocoumacins, 
ochratoxins and cladosporins or asperentins 
(McInerney and Taylor 1995, Lama et al. 
2012, Li et al. 2012). Some respective 
members illustrative of each class are 
depicted in Figure 2 (a) - (e).  
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Figure 2:  Illustrative structures of the different classes of 3,4-dihydroisocoumarins 
 
In addition to the compounds presented in 
Figures 1 and 2, other examples of known 
3,4-DHICs 24-40 (sampled from the 
aforementioned 3,4-DHIC classes) are 
provided in Figures 3-5 (Çitoğlu et al. 2010, 
Braca et al. 2012, Li et al. 2012, Tang et al. 
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2014, Heussner and Bingle 2015).  Even 
with these additional compounds, the list 
only serves to exemplify the diversity of 
structural types of 3,4-dihydroisocoumarins 
and it should not be taken as a 
comprehensive review of the compounds. In 
a recent review, Braca et al. (2012) 
compiled a total of ninety eight (98) 3,4-
DHIC structures. Although the major source 
of 3,4-DHICs are fungi, these compounds 
have also been isolated from some plants, 







24: R1 = CO2Me, R
2 = OH
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Figure 4: Structures  of additional 3-alkyl derivatives, aminocoumacins and a 3-aryl 



























































38 39 40  
Figure 5: Structures of additional ochratoxins (34-37) and cladosporins (38-40) 
 
The 3,4-DHICs are often found together 
with isocoumarins, which are their 
analogues having a C=C between C-3 and 
C-4. Figure 6 depicts a comparison between 




the related coumarin, isocoumarin, 
dihydrocoumarin (3,4-DHC) and 3,4-
dihydroisocoumarin (3,4-DHIC) ring 
systems. Figure 6 also gives some 
nomenclature of these related structural 
types. As it is the case of other classes of the 
natural products, systematic nomenclature is 
rarely used for the 3,4-DHICs and related 
lactones. Thus, almost all naturally 
occurring isocoumarins and 3,4-
dihydroisocoumarins have been given trivial 
names, which are derived from generic or 
specific names of source organism; for 
example mellein (1) [Aspergillus melleus], 
hydrangenol (17) [Hydrangea hortensia], 
cladosporin (23, 38-40) [Cladosporium 













44 = 3,4-DHIC or 
isochroman-1-one















Figure 6: General structures of coumarin, isocoumarin, dihydrocoumarin and 
dihydroisocoumarin (41, 42, 43 and 44, respectively) 
 
Before turning attention to a survey of the 
existing synthetic methodologies, which is 
the focus of this review, it is sensible to at 
least point out the reason why these 
interesting natural products have captured 
the attention from synthetic chemists. 
Essentially, it is because these compounds 
are known to exhibit a range of biological 
activities such as antibacterial, antifungal, 
antimalarial, antiallergic, antitumor, anti-
inflammatory, antiulcer, pheromonal, plant 
growth-promoting and antileukemic 
activities. Other mellein derivatives are 
recognized phytotoxins, neurotoxins, 
hepatotoxins, nephrotoxins and teratogens 
(Kern and Bestmann 1994, el Khoury and 
Atoui 2010, Hope and Hope 2012, Chacón-
Morales et al. 2013). Moreover, these 
secondary metabolites are known to be 
involved in the biosynthetic pathways of 






MELLEIN-TYPE 3,4-DHICs AND 
RELATED LACTONES 
According to Braca et al. (2012), the first 
reported isolation of a 3,4-DHIC dates back 
to 1916 when hydrangenol (17), [Fig. 2 (b)] 
was isolated from the flowers of Hydrangea 
hortensia Smith (Saxifragaceae). Thus, to-
date, this class of naturally occurring 
lactones has existed in the literature for 100 
years.  Despite this long existence and their 
important biological activities, the varieties 
of accessible synthetic strategies have 
remained limited. In this section of the 
review the author endeavors to provide an 
inventory with concise schematic 
descriptions of some reported major 
methods in two categories; synthetic 
strategies that appeared beginning in the 
1950s to 2006 (the past) and the ones that 
have been developed over the last decade 
(the present/current). 
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An Overview of the Past Synthetic 
Approaches (1950s to 2006) 
The work of Blair and Newbold (1955) is 
among the earliest reported direct synthesis 
of 3-methyl-8-methoxy-3,4-DHIC (45), the 
8-methoxy derivative of mellein (1), which 
is taken as the parent compound for other 
simple 3,4-DHICs. Scheme 1 outlines this 























































Scheme 1: Synthesis of 3-methyl-8-methoxy-3,4-DHIC (45) from 3-methoxy-2-nitrobenzoic 
acid 
 
In addition to the synthesis of the -lactone 
45, Blair and Newbold (1955) were able to 
synthesize the isomeric -lactone 46 (3-
ethyl-7-methoxyphthalide) using an 
approach analogous to the above. This 
synthesis is summarized in the Scheme 2. 3-
Methoxy-2-nitrobenzoyl chloride, which is 
the starting material in Scheme 2, was 
obtained from 3-methoxy-2-nitrobenzoic 
acid by treatment with SOCl2.
 

















































Scheme 2: Synthesis of 3-ethyl-8-methoxyphthalide (46) from 3-methoxy-2-
nitrobenzoylchloride 
 
Employing a methodology analogous to the 
one described in Scheme 1, Banerjee and 
Chaudhury (1961) accomplished the 
synthesis of 7,8-dimethoxy-3,4-
dihydroisocoumarin (47) as depicted in 
Scheme 3. The starting material in this 
synthesis is 2-(3,4-dimethoxy-2-
nitrophenyl)acetic acid (48), which was 
obtained from conversion of 4-acetoxy-3-
methoxy-2-nitrobenzaldehyde by adapting a 
known procedure. Compound 48 was 
transformed to the amino alcohol 49 by 
using two different methods (route a and b). 
After obtaining compound 49, these workers 
essentially followed the Blair and Newbold 
(1955) steps to finally assemble the 3,4-
DHIC 47. Consequently, diazotization of the 
amino alcohol 49, conversion of the 
resulting arene diazonium salt into the nitrile 
and subsequent alkaline hydrolysis followed 

























































Scheme 3: Synthesis of 7,8-dimethoxy-3,4-DHIC (47) from 2-(3,4-dimethoxy-2-
nitrophenyl)acetic acid (48) 
 
Matsui et al. (1964) reported the first direct 
synthesis of racemic mellein [i.e., a mixture 
of compounds 1 and 1′, Fig. 1 (a) and 
Scheme 4] from 4-bromo-7-methoxy-
indanone (50) via 3-methyl-8-
hydroxyisocoumarin (51). It is interesting to 
note that the advanced intermediate 51 in 
this synthesis is itself a metabolite obtained 
from Marasmius ramealis. This approach, 
which, like the previous ones described in 
this section, makes use of traditional organic 
reactions, is summarized in Scheme 4. It is 
significant to note that the syntheses 
reported by Blair and Newbold (1955) and 
Matsui et al. (1964) (Schemes 1 and 4, 
respectively) remained the only two known 
syntheses of mellein for more than 35 years 
from the time it was isolated. These two 
syntheses are multi-step and linear 
approaches. However in 1970, Narasimhan 
and Bhide reported a three-step synthesis of 
(±)-mellein (1 and 1′) from o-
methoxybenzoic acid; Scheme 5 outlines 
this synthesis. 
 



























































Scheme 4: Synthesis of racemicmellein (1 and 1′) from 4-bromo-7-methoxy-indanone (50) via 
3-methyl-8-hydroxyisocoumarin (51) 
 
In an approach analogous to the synthesis of 
(±)-mellein summarized in Scheme 5, 
Narasimhan and Bhide (1970) also 
synthesized 8-methoxy-3,4-
dihydroisocoumarin (52), which was easily 
converted into 8-methoxyisocoumarin (53)  
in one step. In this case the ortho lithiated 
benzoic acid derivative was treated with 



































Scheme 5: Synthesis of (±)-mellein (1 and 1′) from o-methoxybenzoic acid by a metallation 
reaction 




In an approach similar to the foregoing, 
Brahmbhatt and Pandya (2003) synthesized 
various 3-aryloxymethyl-3,4-DHICs from 
alkylation of ortho lithiated N-methyl 
benzamides with 2-aryloxymethyl oxiranes. 
Arai et al .(1973) reported a four-step 
synthesis of (±)-mellein (1 and 1′). In this 
synthetic approach, the Diels-Alder reaction 
is utilized as a key step in the construction a 
suitably substituted benzoic acid derivative 
54, which is open to further conversion to 
the target compounds 1 and 1′ (Scheme 6). 
Accordingly, compound 54 was prepared by 
heating a mixture of the acetylenic ester 55 
and 1-methoxycyclohexa-1,4-diene at 180 
°C for 22 h. Obviously, the above reaction 
conditions enabled the latter compound to be 
transformed into 1-methoxycyclohexa-1,3-






















45: R = Me
1 and 1': R = H
BBr3/H2O
 
Scheme 6: Synthesis of (±)-mellein (1 and 1′) by using a Diels-Alder reaction 
 
Henderson and Hill (1982) have reported 
syntheses of several naturally occurring 
chlorinated mellein-type 3,4-DHICs (71-73) 
and isocoumarins (74 and 75). Their 
synthetic approach involved carboxylation 
of the laterally lithiated 3-chloro-, 5-chloro- 
and 3,5-dichloro-2,4-dimethoxy-6-
methylbenzoic acids (56-58) resulting in the 
formation of the corresponding 
homophthalic acids (59-61) as key 
intermediates. The preparation of latter 
compounds and their subsequent chemical 
transformation to the target 3,4-DHICs and 
isocoumarins (71-75) is outlined in Scheme 
7. 
A paper by Bellinger and co-workers (1982) 
reports on the syntheses of some 3-aryl-3,4-
dihydroisocoumarins (3-aryl-3,4-DHICs) by 
both acid-catalyzed and thermal ring closure 
of stilbene-2-carboxylic acids. A number of 
stilbene-2-carboxylic acids were prepared by 
employing a variety of ways, although the 
Wittig reaction was the main approach 
towards these intermediates. To exemplify 
the overall approach, Scheme 8 shows how a 
sample of three isomeric (cis/trans) pairs of 
stilbene-2-carboxylic acids (77-82), 
prepared from the Wittig reaction of the 
phosphonium bromide 76 with 
benzaldehyde, 3-methoxy- and 4-
methoxybenzaldehyde, were chemically 
transformed to the targeted 3-aryl-3,4-
DHICs. Thus, the three 3-aryl-3,4-DHICs 
83-85 represent several others that were 
synthesized in this work. 
 
 










Compound	  R1	   R2
56	                Cl	   H
57	                H	    Cl










Compound	  R1	   R2
59	                Cl	   H
60	                H	    Cl








Compound	  R1	   R2
62	                Cl	   H
63	                H	    Cl










Compound	  R1	   R2
65	                Cl	   H
66	                H	    Cl










Compound	  R1	   R2
68	                Cl	   H
69	                H	    Cl









Compound	  R1	   R2
71	                Cl	   H
72	                H	    Cl







Compound	  R1	   R2
65	                Cl	   H









Compound	  R1	   R2
74	                Cl	   H




Scheme 7: Synthesis of chlorinated 3,4-DHICs (71-73) and isocoumarins (74 and 75) by 
carboxylation of chlorinated 2,4-dimethoxy-6-methylbenzoic acids (56-58) 
 
It must be emphasized that the variety of 
stilbene-2-carboxylic acids prepared and 
further transformed to 3-aryl-3,4-DHICs by 
Bellinger et al. (1982) was not limited to 
compounds 77-82 (Scheme 8). For example, 
the 2ꞌ-methoxy-, 2ꞌ-hydroxy- and 4ꞌ-
hydroxy-substituted stilbene-2-carboxylic 
acids were also prepared and subjected to 
both the acid-catalyzed and thermal ring 
closure reactions. It was observed that only 
the 2ꞌ-hydroxy-, 2ꞌ-methoxy-, 4ꞌ-hydroxy- 
and 4ꞌ-methoxystilbene-2-carboxylic acids 
were thermally converted to the 
corresponding 3-aryl-3,4-DHICs. Guided by 
these observations, the authors proposed a 
mechanism for the thermally induced ring 
closure that possibly involves a reversible 
protonation of the double bond carbon ortho 
to the -CO2H group to give a benzyl 
carbocation, which is resonance-stabilized 
by a methoxy or hydroxy group in 2ꞌ and 4ꞌ 
positions as exemplified by the case of 














Compound	  R1	   R2       R3
77                  H	    H         H
79	                H	   OMe    H









Compound	  R1	   R2       R3
78                  H	    H         H
80	                H	   OMe    H







Compound	  R1	   R2       R3
83                  H	    H         H
84	                H	   OMe    H














Scheme 8: Synthesis of 3-aryl-3,4-DHICs (83-85) by acid-catalyzed and thermal ring closure of 
stilbene-2-carboxylic acids (77-82) 
 
A highly convenient route to 3,4-DHICs by 
means of o-thallation and subsequent 
carbonylation of β-phenethyl alcohols (2-
phenylethyl alcohols) has been reported by 
Larock and Fellows (1982). Table 1 
summarizes the o-thallation and 
carbonylation conditions as well as the 3,4-
DHICs produced from selected β-phenethyl 
alcohols. 
 
For the first time a synthetic approach to 
optically active 3-aryl-3,4-DHICs was 
reported in 1992 by Arnoldi and co-workers. 
In summary, the approach involved the 
utilization of the Corey-Bashki-Shibata 
(CBS) catalyst in the enantioselective 
reduction of aryl 2-carboxybenzyl ketones. 
The ketones were obtained from oxidation 
of the corresponding racemic secondary 
alcohols, which were prepared from the 
condensation of laterally lithiated o-
toluamides with aryl aldehydes. Scheme 9 









Table 1: Synthesis of 3,4-DHICs from β-Phenethyl Alcohols 







Tl(OCOCF3)3, TFA,  
25 °C, 1 day 
0.1 mmol PdCl2, 20 
mmol LiCl,  2 mmol 
MgO or 1 mmol 
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Tl(OCOCF3)3, TFA,  






A communication by Mali et al. (1992) 
reported two novel approaches for the 
syntheses of several naturally occurring (±)-
8-hydroxy-3-methyl-3,4-DHICs and other 
(±)-3-alkyl-3,4-DHICs. The first approach 
(Scheme 10a) involved the treatment of (±)-
3-ethylphthalides 100a-d with anhydrous 
AlCl3 in CH2Cl2 at room temperature for 1-2 
h to give the (±)-8-hydroxy-3-methyl-3,4-
DHICs 101a-e. The (±)-3-ethylphthalides 
100a-d were obtained from the reaction of 
phthalides 99a-d with EtI in the presence of 
LDA. In the second approach (Scheme 10b), 
a mixture of (E)- and (Z)-2-(alk-1-
enyl)benzoic acids 103 and 104 were treated 
with AlCl3 in CH2Cl2 at room temperature to 
give the corresponding (±)-8-hydroxy-3-
methyl-3,4-DHICs  101a, b, e and the (±)-3-
alkyl-3,4-DHICs 105a, b, respectively. The 
(E)- and (Z)-2-(alk-1-enyl)benzoic acids 103 
and 104 were synthesized from 
phthalaldehydric acids 102 and 102ꞌ using 
Wittig reaction. The (±)-7,8-dihydroxy-3-
methyl-3,4-DHIC 101e, obtained from both 
approaches (Scheme 10a and 10b) is a 
product of demethylation at position 7 of 
compound 101b. Moreover, Mali and Babu 
(2001) employed an approach similar to that 
outlined in Scheme 10a to synthesize a 











86: R1 = H
87: R1 = OMe
88: R2 = R3 = H






(±)-90: R1= R2 = R3 = H








92: R1 = R2 = R3 = H
93: R1 = R2 = OMe; R3 = OBz
CONMe2
O













(-)-90:  R1 = R2 = R3 = H






(+)-95: R1 = R2 = R3 = H
1. NaOH/EtOH







(+)-96: R1 = R2 = R3 = H








Scheme 9: Synthesis of optically active 3-aryl-3,4-DHICs (96-98) from optically active 
hydroxyamides 90, 91 and 95 enantioselectively obtained from ketoamides 92-94 


























  99 and 100a: R1 = R2 = H
                    b: R1 = R2 = OMe
                    c: R1 = H; R2 = OMe
                    d: R1 = OMe; R2 = H
              101a: R1 = R2 = H
                    b: R1 = R2 = OMe
                    c: R1 = H; R2 = OMe
                    d: R1 = OMe; R2 = H
                    e: R1 = OH; R2 = OMe
 


























104 (E + Z)
R
102, 103a: R1 = OMe;  R2 = R3 = H
              b: R1 = R2 = R3 =  OMe
102', 104a: R = Me; R1 = R2 = R3 = H
               b: R = Et;   R1 = R2 = R3 = H








101a: R2 = R3 = H
      b: R2 = R3 =  OMe








105a: R = Me; R1 = R2 = R3 = H
      b: R = Et;   R1 = R2 = R3 = H
 
 
Scheme 10b: Synthesis of 3-alkyl-3,4-DHICs 101a, b, e and 105a, b by AlCl3-catalyzed reaction 
of 2-(alk-1-enyl)benzoic acids 103 and 104 
 
As was noted earlier (Scheme 9 vide supra), 
the work reported by Arnoldi et al. (1992) 
represents the first synthetic approach to 
optically active 3-aryl-3,4-DHICs. In this 
work the 3ꞌ-benzyl 8-methyl ether of the 
naturally occurring (R)-(+)-phyllodulcin 
[compound (+)-97, Scheme 9] was obtained 
in only moderate enantiomeric excess (55% 
ee). Compound (+)-98 was obtained in a 
very low ee of 18%. Although the ee for 
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product (+)-96 was not reported, its [α]D was 
found to be +89°. Thus, further efforts were 
directed towards developing more highly 
enantioselective approaches to these 3,4-
DHICs. 
 
Ramacciotti et al. (1996) designed and 
executed a highly enantioselective synthesis 
of a naturally occurring 3-aryl-3,4-DHIC 
phyllodulcin 106. This approach involved 
the Sharpless cis-dihydroxylation of an 
olefinic double bond followed by conversion 
of the cis-dihydroxy product to an optically 
active oxirane (epoxide), namely (S)-(4-
methoxy-3-
triisopropylsilyloxyphenyl)oxirane (107) as 
the intermediate. Scheme 11 outlines this 
enantioselective synthesis of 106 starting 


















































Scheme 11: Enantioselective synthesis of a naturally occurring 3-aryl-3,4-DHIC phyllodulcin 
106 starting with isovanillin (108) via the oxirane 107. 
 
Rama et al. (1998) employed the direct 
condensation of haxadecanoyl and benzoyl 
chlorides with 2-(carboxymethyl)benzoic 
acid (109) to synthesize 3-pentadecyl- and 
3-phenylisocoumarins 110a and 110b, 
respectively. Subsequent alkaline hydrolysis 
of isocoumarins gave the corresponding keto 
acids 111a and 111b, which were further 
transformed to the racemic 3,4-DHICs 112a 
and 112b as depicted in Scheme 12. Hussain 
et al. (2001) employed an approach 
analogous to the foregoing to synthesize 3-
(bromophenyl)isocoumarins (113) and their 
corresponding 3-(bromophenyl)-3,4-DHICs 
(114). Furthermore, a series of isocoumarins 
and corresponding dihydroisocoumarins 
derivatives have synthesized via 
condensation of homophthalic acid with the 
acid chlorides of ibuprofen, fluribiprofen, 
naproxen, valproic acid and 1-naphthoic 
acid (Hussain et al. 2003). 
 








a: R = C15H31
































113, 114a: R1 = Br; R2 = R3 = H
113, 114b: R1 = R3 = H; R2 = Br
113, 114c: R1 = R2 = H; R3 = Br
 
Scheme 12: Synthesis of 3-pentadecyl- and 3-phenylisocoumarins 110a, b and their (d,l)-3,4-
Dihydro Derivatives 112a, b 
 
In a strategy similar to that summarized in 
Scheme 10a (vide supra), Bhide et al. (2002) 
successfully converted some (±)-3-ethyl-3-
methyl phthalides to 3,3-dimethyl-3,4-
DHICs, including 3-methylmellein. 
 
Tactfully, Tahara et al. (2002) were able to 
manipulate reaction conditions so as to 
predominantly achieve either ortho or lateral 
lithiation of 4,4-dimethyl-2-(o-
tolyl)oxazolines 115. Subsequently, the 
condensation of principally lateral and ortho 
lithiated oxazolines 115 with p-anisaldehyde 
followed by treatment of the crude product 
with TFA in aqueous THF gave the 
corresponding 3-aryl-3,4-DHICs 116 and 3-










115a: R1 = R2 = Me, X = H
115b: R1 = R2 = Me, X = OMe
115c: R1 = R2 = Me, X = Cl
115d: R1 = H, R2 = Me, X = H
115e: R1 = R2 = H, X = H
1. sec-BuLi, additive/Et2O
-78 oC
2. p-anisaldehyde, -78 oC








116a: X = H
116b: X = OMe
116c: X = Cl
117a: X = H
117b: X = OMe




Scheme 13: Synthesis of 3-aryl-3,4-DHICs 116a-c and 3-aryl-7-methylphthalides 117a-c by the 
lateral and ortho lithiation of oxazolines 115a-e, respectively. 
 
Utilizing a strategy similar to that 
summarized in Scheme 12, Saeed (2003) 
accomplished a stereoselective synthesis of 
the naturally occurring montroumarin [(3S)-




dihydroisocoumarin (118)]. The starting 
materials in this case were 3,5-
dimethoxyhomophthalic acid and benzoyl 





+ 200 0C O
O


























Scheme 14: Stereoselective Synthesis of Montroumarin 118 by direct condensation of benzoyl 
chloridewith 3,5-dimethoxyhomophthalic acid. 
 
Tahara and collaborators (2004) have 
successfully modified their previous strategy 
(Scheme 13, vide supra) to synthesize 3-
substituted 8-hydroxy-3,4-DHICs in one-pot 
via  the initial sec-BuLi mediated lateral 
lithiation of the oxazoline 115a, followed by 
addition of aldehyde, then treatment of the 
condensation product with sec-BuLi to 
effect the second lithiation, which  is ortho 
lithiation, and  subsequent oxidation to 
introduce the hydroxy group at position 8. 
To complete this one-pot synthesis the crude 
product from the foregoing procedure was 
treated with TFA in refluxing THF/H2O give 
the 3-substituted 8-hydroxy-3,4-DHICs 





1. sec-BuLi, THF, -78 oC
2. RCHO












Scheme 15: Synthesis of 3-substituted 8-hydroxy-3,4-DHICs 119a-i by both lateral and ortho 
lithiation of oxazoline 115a 




Table 2: Synthesis of 3-substituted 8-hydroxy-3,4-DHICs 119a-i by both lateral and ortho 
lithiation of oxazoline 115a 
 











































It is worth mentioning that in the last two 
entries in Table 2, the silyl protecting group 
was removed during the final TFA treatment 
to give the naturally occurring (±)-
hydrangenol (119h) and (±)-phyllodulcin 
(119i). As an extension of the above 
lithiation-based synthetic strategy, Tahara 
and co-workers (2004) developed an 
inexpensive synthesis of (±)-phyllodulcin 
(119i) via the trianion intermediate 120, a 
product of successive lateral lithiation and 
two ortho lithiations in one-pot as 
summarized in Scheme 16. 
 
 





1. sec-BuLi, THF, -78 oC
2. p-anisaldehyde
















Scheme 16: Synthesis of (±)-phyllodulcin (119i) via the trianion intermediate 120 
 
An asymmetric synthesis of 3-substituted 
3,4-DHICs involving the stereoselective 
condensation of aldehydes with the laterally 
lithiated (S)-4-isopropyl-2-(o-tolyl)oxazoline 
(121) followed by a diastereomer-selective 
lactonization of intermediate diastereomers 
122a and 122b has been reported by 
Kurosaki et al.  (2005). Quite a few 
aldehydes were condensed with the laterally 
lithiated optically active 121. Therefore, 
Scheme 17 depicts the reaction of p-
tolualdehyde (123) with 121 and subsequent 
transformation of the adducts 122a and 122b 
to the optically active 3-substituted 3,4-
DHIC 124 to exemplify the procedure used 
for a wide range of aldehydes. It is worth 
mentioning that the (S,S)-diastereomer 122a 
is predominantly formed (77% de) compared 
to (S,R)-diastereomer 122b. Scheme 17 also 
outlines the reaction conditions (i.e., Et2O as 
solvent and TMEDA as the additive, etc.) 
that gave the most satisfactory 
stereoselectivity of the condensation 
reaction in favour of the (S,S) adducts such 
as 122a. Moreover, Scheme 17 also 
illustrates the diastereomer-selective 
lactonization in which the (S,S) adducts such 
as 122a, reacts faster than the (S,R) adducts 
such as 122b to give the optically enriched 





1. sec-BuLi (1.2 eq), Et2O, -78 
oC, 1 h




























TFA, aq. THF, 24 h
 
 
Scheme 17: Synthesis of optically enriched (3S)-3,4-DHICs (e.g. 124) from the optically active 




In the next section of this review, attention is 
focused on the synthetic approaches that 
have appeared over the last decade (2007-
2016). As it was the case in the preceding 
section, the synthetic approaches that will be 
summarized in this section do not constitute 
an exhaustive catalog of all current 
syntheses but rather an instructive selection 
of the currently available methods. 
 
An Overview of the Current Synthetic 
Approaches (2007-2016) 
It is certainly expected that some of the 
current (2007-2016) synthetic methods may 
have similarities to those that were reviewed 
in the preceding section. Consequently, the 
common characteristics of such methods 
will not be repeated in this section; however, 
the reader will be guided so as to access 
information that has already been provided. 
The modifications of such overlapping 
methods or their applications to solve a new 
synthetic problem will be highlighted. 
Qadeer and collaborators (2007) utilized a 
methodology analogous to those described 
in the previous section and summarized in 
Schemes 12 and 14. These researchers 
successfully synthesized the 3-
(dichlorophenyl)isocoumarins (126a-c) and 
their corresponding (±)-3,4-
dihydroisocoumarins (127a-c) by 
condensation of homophthalic acid (109) 

















125, 126, 127 a: R1 = R2 = Br; R3 = R4 = H
125, 126, 127 b: R1 = R3 = H; R2 = R4 = Br










Figure 7: 3-(Dichlorophenyl)isocoumarins (126a-c) and (±)-3,4-DHICs (127a-c)obtained via 
condensation of homophthalic acid (109) with dichlorobenzoyl chlorides 125a-c 
 
An asymmetric synthesis of 3-substituted 8-
hydroxy-3,4-DHICs has been reported by 
Uchida et al. (2007). This approach is very 
similar to that reported by Kurosaki et al. 
(Scheme 17 vide supra). The current 
approach differs from the previous one in 
that a methoxy group is incorporated at 
position 6 of the optically active oxazoline 
121 and, thus, setting the stage for the 
formation of a hydroxy substituent in 
position 8 of the final 3,4-DHIC products. 
This method was applied in the synthesis of 
optically active 3,4-DHIC natural products 
such as (R)-8-hydroxy-3-(1-tridecyl)-3,4-
dihydroisocoumarin and (R)-(+)-
phyllodulcin (106; Scheme 11 vide supra). 
 
A one-step base-catalyzed condensation of 
homophthalic anhydride (128) with aryl or 
heteroaryl aldehydes 129 followed by 
cyclization of the initial condensation adduct 
to give cis/trans-3-aryl(heteroaryl)-3,4-
dihydroisocoumarin-4-carboxylic acids 130 
has been reported by Bogdanov etal. (2007). 
The synthesis of these 3-aryl(heteroaryl)-4-
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 R = Aryl (Ar)  R = Heteroaryl (HetAr) 
a Phenyl e Thiophene-2-yl 
b Benzo[1,3]dioxol-5-yl f Furan-2-yl 
c 4-Nitrophenyl g Pyridin-2-yl 
d N-methylcarbazol-3-yl h Pyridin-3-yl 
  i Pyridin-4-yl 
 
Scheme 18: Synthesis of 3-Ar(HetAr)-4-carboxy-3,4-DHICs (130a-i) via condensation of 
homophthalic anhydride (128) with aryl or heteroaryl aldehydes 129a-i 
 
A paper by Mandal and Roy (2007) reports 
on the utilization of a Cp2TiCl-catalyzed 
Barbier-type radical reaction of aryl and 
alkyl aldehydes with 2-
(bromomethyl)benzoates in the synthesis of 
several 3-substituted 3,4-DHICs. In this 
reaction, the 2-(2-
hydroxyalkyl/aryl)benzoates initially formed 
undergoes lactonization to furnish the 3-
substituted 3,4-DHIC products. To illustrate 
the synthetic utility of this protocol, Scheme 
19 outlines its application in the synthesis of 
(±)-hydrangenol (119h), which is also 
mentioned in Scheme 15 and Table 2 (vide 
supra). 
 
In an approach parallel to the asymmetric 
syntheses published by Kurosaki et al. 
(2005) and Uchida et al. (2007), Sharma and 
co-workers (2010) have reported yet another 
asymmetric synthesis of 3-aryl-3,4-DHICs. 
Unlike the previous strategies, which used a 
chiral auxiliary (fixed to the benzoic acid 
derivative to be laterally and/or ortho 
lithiated), the present strategy employs an 
external chiral base/ligand as the source of 
the asymmetric induction. In other words, 
the two previous approaches involved an 
intramolecular asymmetric induction 
whereas Sharma and co-workers’ approach 





































Scheme 19: Synthesis of the naturally occurring (±)-hydrangenol (119h) via a Cp2TiCl-catalyzed 
Barbier-type radical reaction 
 
The base/ligand used in this synthetic 
approach was the lithium amide obtained 
from (S)-2-(1-pyrrolidinylmethyl)pyrrolidine 
(131.Li). Accordingly, the reaction sequence 
of this intermolecularly induced asymmetric 
synthesis is depicted in Scheme 20. The % 
ee of the 3-aryl-3,4-DHICs  132 obtained at 
-100 °C ranged from  53-68%. It is 
important to mention that the lithium amide 
131.Li was not adequately basic to laterally 
deprotonate oxazoline 115a; consequently, 
115a was laterally deprotonated by sec-BuLi 
followed by addition of 131.Li to play the 





























132a: Ar = phenyl
132b: Ar = p-tolyl
132c: Ar = o-tolyl
132d: Ar = p-methoxyphenyl





Scheme 20: Asymmetric synthesis of 3-aryl-3,4-DHICs 132a-e by an external chiral ligand 
131.Li as the source of the asymmetric induction 
 
A stereoselective synthesis of the (R)-3-
alkyl-3,4-DHICs 134a-d, depicted in 
Scheme 21, has been reported by Rioz-
Martínez et al. (2010). This synthetic 
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strategy involved a dynamic kinetic 
resolution in which the (R)-enantiomers of 
the rac-2-alkyl-1-indanones 133a-d 
underwent a fast enzyme catalyzed Baeyer-
Villiger oxidation to predominantly form the 
(R)-3-alkyl-3,4-DHICs 134a-d. The Baeyer-
Villiger monooxygenase (BVMO) 
responsible for these biocatalyzed oxidations 
was the single mutant of the thermostable 
phenylacetone monooxygenase (M446G 
PAMO) from Thermobifida fusca. The % 
yields and enantiomeric excess of the (R)-3-
alkyl-3,4-DHICs 134a-d ranged from 50-
85% and 50 to ≥97%, respectively. The 
variations were due changes made in 
reaction parameters such as solvent and 
reaction time, which ranged from 48-144 h, 















a: R = Me; b: R = Et; c: = i-Pr; d: R = n-Bu  
 
Scheme 21: Asymmetric synthesis of (R)-3-akyl-3,4-DHICs 134a-e by an enzymatic resolution 
of rac-2-alkyl-1-indanones 133a-d catalyzed by M446G PAMO 
 
Starting with the commercially available 2-
iodobenzoic acid derivatives 135a-d 
(Scheme 22) and hept-1-yne, a Sonogashira 
cross coupling reaction in the presence of 
ZnCl2 was employed by Hampl et al. (2011) 
to synthesize the isocoumarin derivatives 
136a-d. In the presence of ZnCl2, the 
initially formed 2-(hept-1-ynyl)benzoic acid 
derivatives were not isolated as they 
underwent a spontaneous cyclization to give 
the isocoumarins 136a-d. On catalytic 
hydrogenation, the isocoumarins 136a, b 
and d gave the corresponding 5-pentyl-3,4-
DHICs 137a, b and d. 
 
The work by da Penha et al. (2011) applied 
the Heck-Matsuda reaction as the key step in 
the construction of both the 3-substituted 
3,4-DHIC and 3-substituted phthalide 
skeletons from the initially produced 2-(alk-
1-enyl)benzoic acid derivatives in a selective 
way. Whether the cyclization of an 
intermediate 2-(alk-1-enyl)benzoic acid 
derivative gives a 3,4-DHIC or phthalide, is 
governed by the electronic nature of the 
group on the starting olefin. Electron 
donating groups led to formation of 3,4-
DHICs (139a-e, Scheme 23a), whereas 
electron withdrawing groups (EWGs) 

































b: R1 = F; R2 = R3 = H
c: R1 = R3 = H; R2 = Cl
d: R1 = R2 = H; R3 = Me
a: R1 = R2 = R3 = H
b: R1 = F; R2 = R3 = H
c: R1 = R3 = H; R2 = Cl
d: R1 = R2 = H; R3 = Me
a: R1 = R2 = R3 = H
b: R1 = F; R2 = R3 = H
d: R1 = R2 = H; R3 = Me
Conditions: i: Triethylamine, ZnCl2, Pd(PPh3)2Cl2, DMF, 100 °C, 24 h ; 
                   ii: H2 Pd/C, methanol, 25 °C, 12 h  
Scheme 22: Synthesis of 3-pentyl-3,4-DHICs 137a, b, d via the 3-pentylisocoumarins 136a, b, d 
obtained from a Sonogashira reaction as a key step 
 
Consequently, a number of electron rich and 
electron poor olefins were subjected to the 
Heck-Matsuda reaction and followed by 
cyclization to give the 3,4-DHICs and 5-
membered phthalides, respectively. As 
pointed out earlier, Schemes 23a and 23b 
outline this expeditious protocol towards the 







1 mol% Pd(OAc)2, EtOH








a: Ar = phenyl b: Ar = 4-acetoxyphenyl
c: Ar = 4-methoxyphenyl d: Ar = 4-methylphenyl
e: Ar = 4-chlorophenyl
a: Ar = phenyl b: Ar = 4-hydroxyphenyl
c: Ar = 4-methoxyphenyl d: Ar = 4-methylphenyl
e: Ar = 4-chlorophenyl
 
 
Scheme 23a: Synthesis of 3-aryl-3,4-DHICs 139a-e from the electron rich olefins 138a-e by a 





1 mol% Pd(OAc)2, EtOH






a: EWG = 4-nitrophenyl
b: EWG = acetyl




a: EWG = 4-nitrophenyl
b: EWG = acetyl
c: EWG = methoxycarbonyl
or Base
 
Scheme 23b: Synthesis of 3-substituted phthalides 1141a-c from the electron poor olefins 140a-c 
by a Heck-Matsuda reaction as a key step 




Mangas-Sánchez et al. (2012) have reported 
on two chemoenzymatic asymmetric 
transformations that led to enantiopure (S)-
2-(2-hydroxypropyl)benzonitriles 142a-f, 
which were key precursors in the synthesis 
ofthe (S)-3-methyl-3,4-DHICs 144a-f and 
other structurally similar compounds. The 
two chemoenzymatic processes involved in 
this protocol are: a lipase-catalyzed (RML 
IM-catalyzed) kinetic resolution of rac-2-(2-
hydroxypropyl)benzonitriles 142a–f using 
vinyl acetate as an acyl donor and an alcohol 
dehydrogenase-catalyzed (ADH-catalyzed) 
bioreduction of ketones 143a-f. The initial 
preparation of the rac-2-(2-
hydroxypropyl)benzonitriles 142a-f, the 
aforementioned chemoenzymatic processes 
as well as the final cyclization of the 
enantiopure (S)-2-(2-
hydroxypropyl)benzonitriles 142a-f to 
afford the  (S)-3-methyl-3,4-DHICs 144a-f 
is summarized in Scheme 24. 
 
1. BuLi, THF or Et2O









R 2. Propylene oxide, 













aq. media, 30 oC






RML IM, 30 oC











HCl 37 % aq.
NaOH





a: R = H; b: R = 4-Me; c: R = 5-OMe; d: R = 5-Me; e: R = 3-Me; f: R = 4-F
 
 
Scheme 24: Synthesis of enantiopure (S)-3-methyl-3,4-DHICs 144a-f via chemoenzymatic 
transformations 
 
As an extension of the above 
chemoenzymatic method, Mangas-Sánchez 
et al. (2013) have reported a one-pot 
synthesis of enantiopure 4-alkyl-3-methyl-
3,4-DHICs through an E. coli/ADH-A-
catalyzed dynamic reductive kinetic 
resolution as a key step. 
 




In this review we already have come across 
synthetic strategies that make use of 
cyclization of styrene-type carboxylic acids, 
which we have also named stilbene-2-
carboxylic acids or 2-(alk-1-enyl)benzoic 
acids (Schemes 8, 10b, 23a and 23b vide 
supra), in the synthesis of a variety of 3-
substituted 3,4-DHICs. Disappointingly, 
none of these approaches were 
enantioselective and, thus, led to the 
formation of rac-3-substituted 3,4-DHICs. 
Gratifyingly, however, Chen et al. (2012) 
have utilized these styrene-type carboxylic 
acids to effect an asymmetric 
bromocyclization leading to the formation of 
optically active 4-bromo-3,4-DHICs in good 
yields and % ees. The asymmetric induction 
in this method is caused by an amino-
thiocarbamate chiral catalyst such as 




























147:148 = 15:1; Yield 95%, 
% ee 147 = 88



























150:151 = 1:4; Yield 90%, 
% ee 151 = 53





Scheme 25: Enantioselective synthesis of 4-Bromo-3,4-DHICs and phthalides through the 
Bromocyclization of Styrene-type Carboxylic Acids 
 
By fine-tuning some of the reaction 
parameters, such as the electronic nature of 
the olefinic double bond, catalyst, solvent, 
etc., Chen and co-workers could selectively 
obtain either the 4-bromo-3,4-DHICs or the 
equally useful phthalides. More than 20 
different styrene-type carboxylic acid 
substrates were studied in this work; 
therefore, the two shown in Scheme 25 are 
chosen to demonstrate the fact that electron 
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rich olefinic double bonds favoured the 
formation of the 4-bromo-3,4-DHICs (e.g. 
147 vs 148), whereas electron poor olefinic 
double bonds lead to the formation of 
phthalides (e.g. 151 vs 150). It is worth 
mentioning that the  4-bromo-3,4-DHICs 
provides access to the preparation of other 4-
substituted 3,4-DHICs such as the 
biologically important 4-oxy- and 4-N-
substituted 3,4-DHIC systems.  
 
A strategy towards some naturally occurring 
4-oxysubstituted 3,4-DHICs has been 
reported by Fujita et al. (2012). This strategy 
employs a stereoselective oxidative 
lactonization of ortho-alkenylbenzoates in 
the presence of a chiral hypervalent iodine. 
The asymmetric induction is caused by the 
chiral hypervalent iodine reagents 
(Ar
*
I(OAc)2 such as 152 and 153 (Fig. 8). 
 
Starting with the ortho-alkenylbenzoates 
154a-d, the asymmetric synthesis of 4-
hydroxymellein 156a and its analogues 
156b-d, as examples of the many 4-
oxysubstituted 3,4-DHICs synthesized 














































a: R = CH3, X = OAc, Y = OH
b: R = CH3, X = Y = H
c: R = n-C5H11, X = OAc, Y = OH




Scheme 26: Stereoselective synthesis of 4-Hydroxymellein 156a and analogues 156b-d through 
the oxidative lactonization of ortho-alkenylbenzoates 154a-d 
 
Saeed and collaborators (2013) have used a 
method analogous to the methods reported 
by Rama et al. (1998) and Saeed (2003), 
which were summarized in Schemes 12 and 
14 (vide supra), to synthesize 6,8-
dihydroxy-7-methyl-3-styryl-3,4-DHIC 
(159), the analogue of the naturally 
occurring typharin (160). The synthesis was 
achieved through the initial condensation of 
the homophthalic acid derivative 157 with 
cinnamoyl chloride (158) (Fig. 9).  
 
 

















159: R1 = OH, R2 = CH3 160: R




Figure 9: 6,8-Dihydroxy-7-methyl-3-styryl-3,4-DHIC (159), via condensation of 
homophthalic acid derivative (157) with cinnamoyl chloride (158) 
 
A synthesis of substituted 3-alkyl-3,4-
DHICs from the reaction of reaction of o-
(oxiranylmethyl)benzonitriles 161 a-d with 
sodium hydride or Grignard reagent/CuI has 
been reported by Chen et al. (2013). The o-
(oxiranylmethyl)benzonitrile intermediates 
were obtained from isovanillin (108) in five 
steps. The epoxide ring of an o-
(oxiranylmethyl)benzonitrile is opened by a 
nucleophile (NaBH4 or Grignard 
reagent/CuI) to give alkoxide anion which 
attacks the neighboring nitrile to effect an 
intramolecular cyclization. Subsequent 
hydrolysis of the resulting isochroman-1-
imine intermediates gave the substituted 3-
alkyl-3,4-DHICs 162a-d and 163a-d as 




























a: R = Me
b: R = Et
c: R = i-Pr
d: R = n-Bu
 
Scheme 27: 3-Alkyl-3,4-DHICs (162a-d & 163a-d) from o-(oxiranylmethyl)benzonitriles 161a-
d with NaBH4 and PhMgCl/CuI Nucleophiles 
 
A synthetic strategy involving the Meerwein 
arylation of alkyl acrylates and styrenes by 
means of an ortho-alkoxycarbonyl 
arenediazonium bromide with concomitant 
intramolecular cyclization of the 
intermediate ortho-(alk-1-enyl)benzoates 
has been reported to yield 3-
aryl/alkoxycarbonyl-3,4-DHICs 164a-e and 
165a-b (Turytsya et al. 2014). An outline of 
this strategy is shown in Scheme 28. The 
arenediazonium bromide 166 was obtained 
from the commercially available dimethyl 2-
aminoterephthalate. 
 




























a: R1 = H; b: R1 = Me; c: R1 = OMe; d: R1 = F; e: R1 = Cl a: R = Me; b: R = Et
 
 
Scheme 28: Synthesis of 3-aryl/alkoxycarbonyl-3,4-DHICs 164a-e and 165a-b by Meerwein 
arylation reaction 
 
A domino strategy incorporating a Passerini 
3-component-reaction (P-3CR) and an aldol 
condensation has been exploited by Ma and 
co-workers (2014) for the synthesis of 3,4-
DHICs with a richly substituted lactone 
moiety. Two solvent-dependent pathways 
for this Passerini-aldol sequence leads to 
differently substituted 3,4-DHICs. When 
1,4-dioxane is used as the solvent, the 4-
monosubstituted 3,3-disubstituted-3,4-
DHICs 172. On the other hand, using 
methanol as the solvent leads to formation of 
the 4,4-disubstituted 3-monosubstituted-3,4-
DHICs 173. The three components (3Cs) 
required for this domino reaction consist of 
2-formylbenzoic acid derivatives 169, 
isocyanides 170 and arylglyoxals 171. Ma 
and co-workers employed a variety of 
isocyanides and arylglyoxals to react with 2-
formylbenzoic acid. Scheme 29 is a general 
representation of the solvent-dependent 





































Scheme 29: Synthesis of 3,4-substituted 3,4-DHICs 172 and 173 by Passerini-aldol domino 
reaction 
 




A very resourceful Pd(II)-catalyzed ortho 
C(sp
2
)–H alkylation of benzoic acids with 
epoxides has been reported by Cheng et al. 
(2015). The C−H alkylation step occurs via 
a redox-neutral SN2 nucleophilic ring 
opening process similar to the Grignard 
reaction. The free alcohol intermediates 
resulting from alkylation step subsequently 
undergo lactonization to give 3,4-DHICs in 
one pot. The range in the variety of both 
substrates (i.e., the benzoic acid derivatives 
and epoxides) is very wide and, thus, 
making this strategy very practical. Both 
electron donating (e.g. R
1
 = t-Bu, OMe as in 
175a, b) and electron withdrawing groups 
(e.g. R
1
 = CO2Me, CF3 as in 175c, d) in the 
benzoic acid derivatives are well-tolerated in 
this reaction (Scheme 30a). Moreover, both 
terminal (as in 177a-c) and internal epoxides 
(as in 177d, e) are also compatible with this 







































175a 175b 175c 175d
 
Scheme 30a: Synthesis of 3-substituted 3,4-DHICs 175a-d by Pd(II)-catalyzed C−H Alkylation: 










75 oC, 24 h
O
O























Scheme 30b: Synthesis of 3-substituted 3,4-DHICs 177a-e by Pd(II)-catalyzed C−H Alkylation: 
Illustrative Examples of the Epoxide Substrate Scope  
 
By means of a well thought-out Friedel-
Crafts acylation, Vilsmeier-Haack 
formulation and oxidative cyclization, 
Limaye et al. (2015) have accomplished a 
convenient synthesis of the O-methylated 
analogues of the naturally occurring 3-aryl-
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3,4-DHICs montroumarin and thunberginols 
C and D. 3,5-Dimethoxyphenyl acetic acid 
(178), which is the starting material for this 
synthetic protocol, was obtained from 3,5-
dimethoxybenzaldehyde in three steps 
employing a Nef reaction as a key step.The 
synthesis of 3,5-Dimethoxyphenyl acetic 
acid (178) and its subsequent conversion to 
the O-methylated analogues of 
montroumarin (183a) and thunberginols C 
(183b) and D (183c) are summarized in 















Conditions: a: CH3NO2, NH4OAc-AcOH, 80 
oC, 30 min.; b: NaBH4, EtOH-EtOAc 20
 oC - rt, 2 h;
c: NaNO2-AcOH, DMSO, 35















































179a: R = R1 = H
179b: R = H, R1 = OMe
179c: R = R1 = OMe
180a: R = R1 = H
180b: R = H, R1 = OMe
180c: R = R1 = OMe
181a: R = R1 = H
181b: R = H, R1 = OMe
181c: R = R1 = OMe
182a: R = R1 = H
182b: R = H, R1 = OMe
182c: R = R1 = OMe
183a: R = R1 = H
183b: R = H, R1 = OMe
183c: R = R1 = OMe
Conditions: a (i): SOCl2, reflux, 1 h (ii) Benzene or anisole or 1,2-dimethoxybenzene, AlCl3, rt, 2 h; b: 
NaBH4/MeOH rt, 1 h; c: Ac2O/Pyridine, rt, 1 h; d: DMF-POCl3 0 
oC-rt, 3 h; e (i): KMnO4, dioxane-H2O, 
80 oC, 45 min. (ii) conc. HCl, 80 oC, 30 min.
 
 
Scheme 32: Synthesis of O-methylated analogues of montroumarin (183a) and thunberginols C 
(183b) and D (183c). 
 
Essig and Menche (2016) have reported 
aninnovative method for the stereoselective 
synthesis of the 4-hydroxy 3,4-DHIC moiety 
present in many bioactive natural products 
including the ajudazols. The method is based 
on an ortho lithiation and asymmetric 
condensation with aldehyde electrophiles as 
the key step. The stereocontrol in this 
condensation reaction is due to the chiral 
memory of a preoriented atropisomeric 




amide axis. The amide with preoriented 
atropisomeric amide axis (the aromatic 
reaction partner for the ortho lithiation) was 
obtained from functionalization of 3-
methylsalicylic acid. The aldehyde 
electrophiles developed in this strategy 
consisted of one or two stereogenic centres 
and, therefore, allowing access to different 
stereoisomers of the 4-hydroxyl-3,4-DHICs 
with up to three adjacent stereocenters; these 
stereochemical features are present in many 
bioactive 3,4-DHICs including the 
ajudazols. In order to achieve the 
lactonization step, the authors developed 
efficient procedures for the cleavage of 
sterically hindered amides; these procedures 
involve either O-alkylation of the amide 
with MeOTf or the utilization of acetic acid 
under microwave activation. The design of 
this conceptually novel approach to the 4-
hydroxy-3,4-DHICs is shown in Scheme 33 



























Scheme 33: Design of a Novel Approach towards the 4-Hydroxy-3,4-DHICs with up to Three 
Adjacent Stereocentres  
 
After the appraisal of some past (1950s-
2006) and present (2007-2016) synthetic 
approaches toward the mellein-type 3,4-
DHICs and related lactones, the overall 
state, in terms of the frequently used 
synthetic strategies, comes into view. 
Moreover, the commonly employed 
synthetic intermediates/starting materials 
have been revealed. In the next section the 
author strives to describe ways in which 
some of the synthetic intermediates 
encountered in the preceding section could 
be derived from anacardic acid, an 
inexpensive renewable resource. Therefore, 
the next section, in conjunction with 
knowledge of the existing synthetic 
methodologies described above, presents a 
researcher with the choice of conceiving a 
synthetic route towards the title compounds 




MELLEIN-TYPE 3,4-DHICs AND 
RELATED LACTONES FROM 
ANACARDIC ACID  
The preceding section of this review has 
revealed that the existing major synthetic 
approaches towards the mellein-type 3,4-
DHICs have included the traditional 
multistep syntheses involving benzoic acid, 
phenylacetic acid and homophthalic acid 
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derivatives, ortho and lateral lithiation of 
benzoic acid derivatives, Diels-Alder 
reaction of acetylenic dienophiles with 
cyclohexa-1,3-dienes, direct thermal 
condensation of acid chlorides with 
homophthalic acid and acid-catalyzed or 
thermal cyclization of  ortho-(alk-1-
enyl)benzoic acid derivatives. In recent 
years, asymmetric approaches involving 
chiral auxiliary oxazolines, chiral catalysts 
and chemoenzymatic protocols have 
emerged. Moreover, Pd-catalyzed cross 
coupling reactions (e.g. the Sonogashira and 
Heck-Matsuda reactions) and C(sp
2
)–H 
alkylation of benzoic acid derivatives have 
also been employed in recent times. Other 
metal-catalyzed methods including the 
CuBr-catalyzed Meerwein arylationof 
acrylates or styrenes and the Cp2TiCl-
catalyzed Barbier-type radical reactions 
have also featured among the synthetic 
methodologies toward the title compounds. 
 
Despite the apparent diversity in synthetic 
approaches highlighted above, the key 
synthetic precursors/intermediates have, 
however, remained limited to primarily 
benzoic acid derivatives. It is in this light 
that this section seeks to propose ways on 
how some of the intermediates encountered 
in this review can be obtained from 
anacardic acid, which is a relatively 
abundant naturally occurring benzoic acid 
derivative. Precedence is available from the 
recently published work by Mgaya et al. 
(2015) in which the anacardic acid 
component of CNSL was utilized as the raw 
material in the synthesis of 8-hydroxy-3-
tridecyl-3,4-dihydroisocoumarin (184). 
Figure 10 shows the structures of compound 















Figure 10: Structure of 8-hydroxy-3-tridecyl-3,4-dihydroisocoumarin (184) prepared from 
anacardic acid (185) 
 
Prior to the presentation of the intended 
schematic description of ways in which 
anacardic acid (185) can chemically be 
manipulated to afford some synthetic 
precursors open to further conversion to 3,4-
DHICs, it would be prudent to briefly 
comment on its chemical constitution. As 
shown in Figure 10, anacardic acid is in 
essence a salicylic acid derivative. The C15 
substituent at position 6 occurs as a mixture 
of a pentadecyl, 8Z-pentadecenyl, 8Z,11Z-
pentadecadienyl and 8Z,11Z,14-
pentadecatrienyl carbon chain. However, it 
is significant to note that the monoenyl (8Z-
pentadecenyl) side chain constitutes the 
predominant sub-structure of anacardic acid; 
consequently, anacardic acid is often 
formulated as a single compound containing 
the monoenyl (8Z-pentadecenyl) side chain. 
 
With the foregoing structural clarification in 
mind, Schemes 34 and 35 graphically 
summarizes the proposed routes to some of 
the key intermediates for the synthesis of 
3,4-DHICs. The conversion of anacardic 
acid (185) to isoanacardic acid [i.e., 
(E)‐2‐hydroxy‐6‐(pentadec‐1‐enyl)benzoic 
acid (186)] is at the core of these ideas 




proposed herein. This has already been 
accomplished by Mgaya et al. (2015) and 
Kisula (2015) by applying different 









































Scheme 34: Conversion of anacardic acid (185) to isoanacardic acid (186) by two different 
protocols. 
 
As pointed out earlier, Mgaya and co-
workers (2015) successfully converted 
isoanacardic acid (186) to 3-tridecanyl-3,4-
DHIC 184 (Fig. 10 and Scheme 34). 
Moreover, compound 188 was obtained 
from the same source by an alkene 
metathesis reaction using cis-2-butene. In 
this review we already have encountered the 
methyl ether (i.e, the 2-methoxy derivative 
103a, Scheme 10b) of compound 188. This 
imply that isoanacardic acid, obtained from 
anacardic acid, is a viable source of 
compound 188, a key intermediate toward 
the mellein-type 3,4-DHICs. At this point, 
the author would like to focus attention on 
the potential of 6-formyl-2-hydroxybenzoic 
acid (187), obtained from ozonolysis of 
isoanacardic acid, as a key synthetic 
precursor towards the title compounds. 
Earlier in this review we came across the 2-
methoxy derivative of compound 187 (i.e., 
compound 102a Scheme 10b vide supra) as 
a precursor in the synthesis of a mellein-type 
3,4-DHIC. Scheme 35 outlines some routes 
toward other synthetic precursors utilizing 
compound 187 as the hub. 
 
 















































































Scheme 35: Conversion of aldehyde 187 obtained from anacardic acid (185) to diverse synthetic 
precursors (188-197) 
 
The phthalides 189a, b, benzyl alcohols 
190a, b, homophthalic acids 191, 2-(alk-1-
ynyl)benzoic acid derivatives 192, 
homophthalic anhydrides 193, 2-(2-chloro-
2-oxoethyl)-6-hydroxybenzoic acid 
derivatives 194, keto acids 195, β-phenethyl 
alcohols [or 2-(2-hydroxyalkyl/aryl)benzoic 
acid derivatives] 196a, b, 2-
(halomethyl)benzoic acid derivatives 197 
and 6-methylsalicylic acid 198 and its 
derivatives were among the most frequently 
encountered precursors/intermediates 
described in this review. Schemes 34 and 35, 
therefore, demonstrates the potential of 
utilizing CNSL phenolic constituents in the 
syntheses of 3,4-DHICs since all the above 
mentioned synthetic precursors can be 
obtained from anacardic acid (185) via 
isoanacardic acid (186) and 6-formyl-2-
hydroxybenzoic acid (187). Consequently, 
we have initiated synthetic work utilizing 
anacardic acid as well cardanol and cardol, 
the other major components of CNSL, for 
syntheses of some of the above fine 
chemicals and others as well as natural 








This review has brought together some of 
the earliest (past) and the more recent 
(present) synthetic methodologies toward 
the mellein-type and other 3,4-DHICs. 
Moreover, the review has simultaneously 
proposed potential (projected) synthetic 
strategies focusing on the utilization of 
anacardic acid from Cashew Nut Shell 
Liquid (CNSL) - a readily available natural 
resource. The utilization of CNSL extracted 
from the agro-waste Cashew Nut Shells 
(CNS) will add value to the cashew crop. 
Therefore, this paper provides a synopsis of 
the existing and some potential synthetic 
routes toward melleins and other 3,4-DHICs 
and, thus, inspire and give opportunities to 
researchers to choose and apply one or a 
combination of these synthetic strategies 
depending on the research resources and 
facilities are available to them. Work 
employing some of the proposed strategies 
is in progress in our laboratories and results 
will be reported in the near future. 
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